Special Diabetes Program Reauthorization Act of 2023

This bill extends the Special Diabetes Program for Type 1 diabetes through 2028, continuing existing federal funding that supports research, prevention, and treatment initiatives. It directly affects people living with Type 1 diabetes by ensuring ongoing access to critical resources funded under the Public Health Service Act. The key provision amends Section 330B(b)(2)(D) to update the program's funding period from ending in 2023 to ending in 2028. This is a straightforward reauthorization of current funding levels without new program requirements or eligibility changes.